ANAVEX LIFE SCIENCES CORP. 10-Q

Item 5. Other Information. None. 32 Item 6. Exhibits. Exhibit Number Description (3) Articles of Incorporation and Bylaws 3.1 Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed on May 9, 2019) 3.2 Certificate of Amendment to Articles of Incorporation (incorporated by reference to our Current Report on Form 8-K filed on May 28, 2021) 3.3 Bylaws (incorporated by reference to our Current Report on Form 8-K filed on September 28, 2007) 3.4 Articles of Merger filed with the Secretary of State of Nevada on January 10, 2007 and which is effective January 25, 2007 (incorporated by reference to our Current Report on Form 8-K filed on January 25, 2007) (31) Rule 13a-14(a)/15(d)-14(a)Certifications 31.1* Certification of Christopher Missling, PhD. 31.2* Certification of Sandra Boenisch (32) Section 1350 Certifications 32.1* Certification of Christopher Missling, PhD and Sandra Boenisch. (101) XBRL 101.INS* XBRL INSTANCE DOCUMENT 101.SCH* XBRL TAXONOMY EXTENSION SCHEMA 101.CAL* XBRL TAXONOMY EXTENSION CALCULATION LINKBASE 101.DEF* XBRL TAXONOMY EXTENSION DEFINITION LINKBASE 101.LAB* XBRL TAXONOMY EXTENSION LABEL LINKBASE 101.PRE* XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE * Filed herewith. 33 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ANAVEX LIFE SCIENCES CORP. /s/Christopher Missling, PhD Christopher Missling, PhD Chief Executive Officer (Principal Executive Officer) Date: August 12, 2021 /s/Sandra Boenisch Sandra Boenisch, CPA, CGA Principal Financial Officer (Principal Financial and Accounting Officer) Date: August 12, 2021 34